Stocks on the Move: Fidus Investment Corporation (NASDAQ:FDUS), The Goldman Sachs Group (NYSE:GS), Opexa Therapeutics (NASDAQ:OPXA), W.R. Grace & Co. (NYSE:GRA)

FTI Consulting, Inc. (NYSE:FCN) shares advanced 0.37% in last trading session and ended the day at $35.64. FCN Gross Margin is 34.20% and its has a return on assets of 2.80%. FTI Consulting, Inc. (NYSE:FCN) quarterly performance is 0.68%.

On 31st March, FTI Consulting, Inc. (NYSE:FCN), the global business advisory firm dedicated to helping organizations protect and enhance their enterprise value, released the first installment of the Company’s Corporate Issues Study, which takes an in-depth look at the role investor confidence plays when it comes to evaluating a variety of corporate issues.

Fidus Investment Corporation (NASDAQ:FDUS) ended the last trading day at $15.53. Company weekly volatility is calculated as 2.27% and price to cash ratio as 7.99. Fidus Investment Corporation (NASDAQ:FDUS) showed a weekly performance of 0.26%.

On 01 April, The Goldman Sachs Group, Inc. (NYSE:GS) shares advanced 1.81% and was closed at $159.82. GS EPS growth in last 5 year was -1.60%. The Goldman Sachs Group, Inc. (NYSE:GS) year to date (YTD) performance is -10.94%.

Goldman Sachs Group Inc. (NYSE:GS) is sticking to its view that Fed officials will raise rates three times this year. It’s in line with its earlier call, but the forecast comes after Federal Reserve Chair Janet Yellen sounded a cautious tone in remarks this week, which sent investors into risk-on mode as they dialed back their interest-rate expectations.

Opexa Therapeutics, Inc. (NASDAQ:OPXA) shares advanced 8.63% in last trading session and ended the day at $2.52. OPXA has a return on assets of -77.60%. Opexa Therapeutics, Inc. (NASDAQ:OPXA) quarterly performance is -9.07%.

On March 25, 2016, Opexa Therapeutics, Inc. (NASDAQ:OPXA) entered into that certain Sales Agreement (the “Agreement”) with IFS Securities, Inc. (doing business as Brinson Patrick, a division of IFS Securities, Inc.) (the “Sales Agent”), under which the Company may sell shares of its common stock from time to time depending upon market demand, with the Sales Agent acting as an agent for sales. Pursuant to the Agreement, the Company may offer and sell the shares in transactions deemed to be an “at-the-market” offering as defined in Rule 415 of the Securities Act of 1933. The Agreement replaces that certain Sales Agreement dated September 6, 2012, as amended on March 5, 2014 (as amended, the “Original Sales Agreement”), between the Company and Meyers Associates, L.P.

W.R. Grace & Co. (NYSE:GRA) caters to the Basic Materials space. It has a net profit margin of 4.70% and weekly performance is 6.12%. On the last day of trading company shares ended up at $74.93. W.R. Grace & Co. (NYSE:GRA) distance from 50-day simple moving average (SMA50) is 3.05%.

On 25 March, it was reported W.R. Grace & Co. (NYSE:GRA) executives can’t emerge from bankruptcy protection every year. The top brass at Columbia-based chemical-maker Grace (NYSE: GRA) felt a drop in compensation in 2015, according to the company’s proxy statement filed.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *